Clinical Trials
Signant Health and ActiGraphsimplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraph’s Centre Pointsystem. The integration, which includes ActiGraph’s FDA 510(k) cleared sensors, helps simplify the process of...
Clinical Trials
Thermo Fisher launches IonicX XRF Analyzer to identity ionic salts
Thermo Fisher Scientific has launched a new handheld X-ray fluorescence analyser called IonicX XRF Analyzer to help pharmaceutical and biopharmaceutical manufacturers to verify the identity of ionic salts in warehouses within seconds.
According to the life sciences company, the technology...
Clinical Trials
WFS awarded GDP certifications for Johannesburg and Cape Town pharma facilities
Worldwide Flight Services (WFS) has become the first air cargo handling company in South Africa to be awarded Good Distribution Practice (GDP) certifications for its temperature controlled pharma facilities, aligned to ISO9001:2015, in Johannesburg and Cape Town.
This latest WFS...
Clinical Trials
Cytel to hold Complex Innovative Trial Design Symposium
Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences industry, has announced that the Complex Innovative Trial Design Symposium and East® Training will take place November 6–7 at Alexion’s headquarters in...
Clinical Trials
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety and tolerability of AVID200, a first-in-class TGF-beta 1 & 3 selective inhibitor, administered as...
Clinical Trials
MabThera meets primary endpoint in PEMPHIX trial in pemphigus vulgaris
Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52.
The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the...
Clinical Trials
WellVia partners with Health Gorilla to power clinical record retrieval and lab ordering
Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced a partnership that enables new data exchange capabilities within the WellVia telehealth platform. WellVia will utilize Health Gorilla's FHIR APIs to equip healthcare providers...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.